Synthetic antimicrobial peptides: From choice of the best sequences to action mechanisms

The emergence of antibiotic-resistant microbes has stimulated research worldwide seeking new biologically active molecules. In this respect, synthetic antimicrobial peptides (SAMPs) have been suggested to overcome this problem. Although there are some online servers that provide putative SAMPs from...

Full description

Saved in:
Bibliographic Details
Published inBiochimie Vol. 175; pp. 132 - 145
Main Authors Souza, Pedro F.N., Marques, Lidyane S.M., Oliveira, Jose T.A., Lima, Patrícia G., Dias, Lucas P., Neto, Nilton A.S., Lopes, Francisco E.S., Sousa, Jeanlex S., Silva, Ayrles F.B., Caneiro, Rômulo F., Lopes, Jose L.S., Ramos, Márcio V., Freitas, Cleverson D.T.
Format Journal Article
LanguageEnglish
Published France Elsevier B.V 01.08.2020
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The emergence of antibiotic-resistant microbes has stimulated research worldwide seeking new biologically active molecules. In this respect, synthetic antimicrobial peptides (SAMPs) have been suggested to overcome this problem. Although there are some online servers that provide putative SAMPs from protein sequences, the choice of the best peptide sequences for further analysis is still difficult. Therefore, the goal of this paper is not to launch a new tool but to provide a friendly workflow to characterize and predict potential SAMPs by employing existing tools. Using this proposed workflow, two peptides (PepGAT and PepKAA) were obtained and extensively characterized. These peptides damaged microbial membranes and cell walls, and induced overproduction of reactive oxygen species (ROS). Both peptides were found to assume random coil secondary structure in aqueous solution, organic solvent, and upon binding to negatively charged lipid systems. Peptides were also able to degrade formed biofilms but not to prevent biofilm formation. PepGAT was not resistant to proteolysis, whereas PepKAA was resistant to pepsin but not to pancreatin. Furthermore, both presented no hemolytic activity against red blood cells, even at a 10-fold higher concentration than the antimicrobial concentration. The pipeline proposed here is an easy way to design new SAMPs for application as alternatives to develop new drugs against human pathogenic microorganisms. •Here is provided a workflow to facilitate the design of synthetic peptides.•Employing the workflow was possible to design two antimicrobial peptides.•PepGAT and PepKAA are potent antimicrobial peptides.•Both peptides have activity against human pathogenic bacteria and fungi.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0300-9084
1638-6183
DOI:10.1016/j.biochi.2020.05.016